ABL Exhibits at Phacilitate Vaccine Forum

ABL participated at the Phacilitate 2013 Vaccine Forum in Washington, DC from January 28 to January 30.

Phacilitate 2013 featured three forums: the Vaccine Forum, the Cell and Gene Therapy Forum, and Protein Therapeutics Forum. Members of ABL’s scientific, manufacturing, and business development staff attended the Phacilitate conference. ABL met with other scientists and organizations involved in biotech and biopharmaceutical industry. As an industry leader in development of vaccines and therapeutics, ABL feels that it is important to foster communication and collaboration throughout the field.